Pipeline

Herantis has a strong product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Our focus is on innovative, novel medicinal products for the treatment of indications with an unmet clinical need. We aim to develop our products through clinical Proof-of-Concept and partner with large pharmaceutical or biotech companies for late stage development and commercialization.

Drug candidate portfolio

Product Target Preclinical Phase 1 Phase 2 Phase 3 Launched
Cis-UCA Eye Drops Dry Eye* X X X
CDNF Parkinson’s Disease* X
Lymfactin® Secondary lymphedema* X X
Cis-UCA Emulsion Cream Atopic dermatitis X X X
CDNF Amyotrophic Lateral Sclerosis X

*CURRENTLY UNDER ACTIVE CLINICAL DEVELOPMENT: CLINICAL STUDIES ONGOING OR PLANNED